Mulay Diagnostic Services Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-07-2024
- Paid Up Capital ₹ 0.30 M
as on 04-07-2024
- Company Age 32 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.89 M
as on 04-07-2024
- Revenue 19.44%
(FY 2022)
- Profit -240.00%
(FY 2022)
- Ebitda 637.72%
(FY 2022)
- Net Worth -1.06%
(FY 2022)
- Total Assets -10.88%
(FY 2022)
About Mulay Diagnostic Services
The Corporate was formerly known as Mulay Metropolis Healthcare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹6.89 M.
Sukhada Mulay, Himanshu Mulay, and Dilip Mulay serve as directors at the Company.
- CIN/LLPIN
U85195MH1992PTC065228
- Company No.
065228
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Feb 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mulay Diagnostic Services?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sukhada Mulay  | Director | 04-Feb-1992 | Current |
| Himanshu Mulay | Director | 26-Jul-2019 | Current |
| Dilip Mulay | Director | 04-Feb-1992 | Current |
Financial Performance and Corporate Structure Insights of Mulay Diagnostic Services.
Mulay Diagnostic Services Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.44% increase. The company also saw a substantial fall in profitability, with a 240% decrease in profit. The company's net worth dipped by a decrease of 1.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mulay Diagnostic Services?
In 2019, Mulay Diagnostic Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Saraswat Co-Operative Bank Limited Creation Date: 31 Mar 2010 | ₹2.43 M | Open |
The Saraswat Co-Operative Bank Limited Creation Date: 31 Jan 2007 | ₹0.46 M | Open |
The Vysya Bank Ltd. Creation Date: 07 Dec 1994 | ₹4.00 M | Open |
How Many Employees Work at Mulay Diagnostic Services?
Unlock and access historical data on people associated with Mulay Diagnostic Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mulay Diagnostic Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mulay Diagnostic Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
